Isodiol International LLC (CSE:ISOL, OTC:LAGBF, FSE:LBGA.F) (the “Company” or “Isodiol”), a global CBD innovator specializing in the development of wellness products, proudly announces that it has reached a partnership agreement with Cage Warriors, Europe’s leading Mixed Martial Arts (MMA) promotion through its brand ISO-Sport.  The Company will launch the European roll out of ISO-Sport™ at the Cage Warriors upcoming show in Liverpool, England on February 24th 2018, which will be aired on UFC Fight Pass.

Cage Warriors prides itself on being the proving ground for MMA’s stars of the future and has been home to some of biggest stars of MMA’s past and present, including Conor McGregor, Michael Bisping, and Dan Hardy.  In addition to promoting and staging shows throughout the year, Cage Warriors is also investing in the future development of the sport of MMA through its Cage Warriors Academy Network.


The Company and Cage Warriors will work together to promote ISO-Sport™ and grow the Company’s business in the European market.  This sponsorship is designed to promote athlete wellness and makes ISO-Sport™ the official Partner of Cage Warriors for all sport supplements, hydration and nutrition products.

“Cage Warriors is the home to many of the best MMA fighters around the world, making this partnership an easy decision for us,” said President of ISO-Sport™, Troy Nihart.  “ISO-Sport™ will begin to develop new innovative products specifically for MMA fighters to help throughout their daily lives, training and recovery process.  We are excited about the tremendous amount of exposure this partnership will provide to the ISO-Sport™ brand.”

“This partnership with Isodiol is exciting,” said Cage Warriors President Graham Boylan. “Their commitment to athlete well-being has impressed us; and we will work with them to build their business in our markets – helping them develop the right products for athletes within MMA and in other European sports too.”

For more information on ISO-Sport™, please visit www.iso-sport.com

About Isodiol International Inc.

Isodiol International Inc. is the market leader in pharmaceutical grade phytochemical compounds and the industry leader in the manufacturing and development of CBD consumer products.

Isodiol is the pioneer of many firsts including the commercialization of 99%+ pure, bioactive pharmaceutical grade CBD, micro-encapsulations, and nanotechnology for the highest quality consumable and topical skin care products.

Isodiol’s growth strategy includes the development of over-the-counter and pharmaceutical CBD drugs, expanding its phytoceutical portfolio and will aggressively continue international expansion into Latin America, Asia and Europe.

About Cage Warriors:

Cage Warriors is Europe’s leading and longest-running MMA promotion, and has launched the careers of many of the biggest names in the sport including Conor McGregor. Its mission is to showcase the best of European MMA and provide local heroes with a platform to achieve global greatness. Cage Warriors events are known for providing incredible atmosphere, high production values and showcasing amazing fight action from some of the toughest athletes in Europe. Shows are broadcast live on UFC fight pass, BT Sport, ViaSat, Channel Eleven and various other broadcast partners.

ON BEHALF OF THE BOARD

Marcos Agramont, CEO & Director

INVESTOR RELATIONS:

Ir@isodiol.com

www.isodiol.com

Forward-Looking Information: This news release contains “forward-looking information” within the meaning of applicable securities laws relating to statements regarding the Company’s business, products and future the Company’s business, its product offerings and plans for sales and marketing. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned to not place undue reliance on forward-looking information. Such forward looking statements are subject to risks and uncertainties that may cause actual results, performance and developments to differ materially from those contemplated by these statements depending on, among other things, the risks that the Company’s products and plan will vary from those stated in this news release and the Company may not be able to carry out its business plans as expected. Except as required by law, the Company expressly disclaims any obligation, and does not intend, to update any forward-looking statements or forward-looking information in this news release. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct and makes no reference to profitability based on sales reported. The statements in this news release are made as of the date of this release.

The CSE has not reviewed, approved or disapproved the content of this press release.

Source: Isodiol

Click here to connect with Isodiol International LLC (CSE:ISOL, OTC:LAGBF, FSE:LBGA.F) and receive an Investors Presentation. 

Source: www.nasdaq.com

The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less

The Israeli cannabis market is picking up as a Canadian producer announced a new supply deal in the country.

Also this week it was shown the sales of Canadian cannabis edible products may be stalling, according to new data.

Keep reading... Show less

The Portnoy Law Firm advises investors that class action lawsuits have been filed on behalf of investors in the following publicly traded companies. Shareholders interested in taking an active role in these cases have until the deadlines indicated below to petition the court. There is no cost or obligation to you. See below for more information on these cases.

Credit Acceptance Corporation investors (NASDAQ: CACC); December 1, 2020 deadline, click here to join .

Keep reading... Show less
  • On November 19 , the Mexican Senate passed comprehensive adult-use cannabis legalization, moving Mexico towards becoming one of the few countries to legalize cannabis nationally
  • On March 31, 2020 , the Company entered into an agreement with Tecnologico de Monterrey , the leading university in Mexico , to educate physicians across Latin America , in advance of the impending regulations in Mexico
  • To date, close to 550 LatAm physicians have obtained their diploma accrediting completion of Khiron’s medical education program
  • The Company plans to deploy its ZereniaTM medical cannabis clinics and telehealth strategy in Mexico , building on the success of its vertical integration strategy in Colombia
  • Expanding the Zerenia clinic strategy will build on the Company’s Colombia knowledge and proven distribution capabilities, with rapid telehealth service adoption and over 5,600 medical cannabis scripts filled to date
  • Mexico represents one of the largest potential markets for medical cannabis in the world and is anticipated to reach $1.2bn USD by 2028 (Prohibition Partners).
  • Company to release Q3 2020 financials and host webcast on Tuesday, December 1st

Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN ), (OTCQX: KHRNF), ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe welcomes the passing of adult-use cannabis legislation by the Mexican Senate, which moves the country closer to a legalized cannabis market, and towards provision for medical cannabis products.  Khiron has had a presence in Mexico since 2018 and has been working with doctors and medical institutions to develop a deep understanding of the market.

Keep reading... Show less

Recap of special management call includes upcoming corporate milestones and details of proposed combination with established beverage manufacturer

Emerging leader in infused cannabis beverages, BevCanna Enterprises Inc. (CSE:BEV, OTCQB:BVNNF, FSE:7BC) (“BevCanna” or the “Company”) is pleased to provide a recorded recap of the special management call held on Tuesday November 24, 2020. The call discussed upcoming corporate milestones and reviewed recent developments at the developer and manufacturer of cannabinoid‐infused beverages and consumer products for in‐house brands and white label clients.

Keep reading... Show less